A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient

PHASE3CompletedINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Hypertension
Interventions
DRUG

Amlodipine

Amlodipine 5mg/ day

DRUG

Amlodipine

Amlodipine 10mg/ day

Trial Locations (14)

Unknown

Pfizer Investigational Site, Kasuya-gun

Pfizer Investigational Site, Chikushino-shi

Pfizer Investigational Site, Kitakyushu

Pfizer Investigational Site, Koga

Pfizer Investigational Site, Sapporo

Pfizer Investigational Site, Yokohama

Pfizer Investigational Site, Iruma

Pfizer Investigational Site, Koshigaya

Pfizer Investigational Site, Adachi-ku

Pfizer Investigational Site, Edogawa-ku

Pfizer Investigational Site, Meguro-ku

Pfizer Investigational Site, Setagaya-ku

Pfizer Investigational Site, Sumida City

Pfizer Investigational Site, Fukuoka

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00415623 - A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient | Biotech Hunter | Biotech Hunter